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TABLE I
IN VITRO PROCESSING OF THE Yf PRECURSOR
Percent of polypeptide species lost
Cellular fractions after 60-min incubation at 370C
added
fl-Galactosidase 87 kd Precursor
None
-ATP <2 <2
+ATP <2 5
Supernatant
-ATP <2 5
+ATP <2 8
Membrane
-ATP <2 12
+ATP <2 32
Membrane +
Supernatant
-ATP <2 11
+ATP <2 34
mechanism of precursor processing. These experiments
suggest that the precursor can be modified by an ATP-
dependent membrane component in vitro. Aliquots of a
double-label Yr supernatant fraction were incubated with
supernatant and/or membrane fractions prepared from
unlabeled cells. Incubations were performed in the absence
or presence of 2 mM ATP since it has been recently
demonstrated that several of the more interesting proteo-
lytic enzymes are ATP dependent (Charette et al., 1981).
In a typical experiment, incubations were at 370C for 60
min and the reaction was terminated by heating at 500C in
SDS-gel sample buffer. The samples were fractionated by
SDS-PAGE and analyzed as described (Fried, 1981). The
effect of various cellular fractions and ATP on the
recovery of f-galactosidase (an internal control) and the
precursor are summarized in Table I. The various incu-
bations did not affect j3-galactosidase, a well-characterized
stable protein. The precursor was not processed either by
itself or when incubated with the supernatant fraction in
the presence of ATP. In contrast, addition of membranes
stimulated the loss of precursor and this was enhanced
threefold by addition of ATP. No synergism was observed
when supernatant and membrane fractions were both
present. While these experiments demonstrated a specific
loss of precursor, the appearance of the 30 kd membrane
protein was not consistently observed. This may be due to
the low sensitivity in the double-label analysis. On the
other hand, material was found to accumulate at the top of
the separating gel in a broad smear and could account for
the loss of the precursor. The mature permease aggregates
and runs in the same pattern when heated above 500C
(Fried, 1981). It is possible that intermediates in the
processing of the precursor in vitro may be more suscep-
tible to aggregation at 500C. Experiments are in progress
to determine the fate of the precursor in the in vitro
system.
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FUSION AND DISASSEMBLY OF SENDAI VIRUS
MEMBRANES WITH LIPOSOMES
ANNE M. HAYWOOD AND BRADLEY P. BOYER
Departments ofPediatrics and Microbiology, University ofRochester, Rochester, New York 14642
U.S.A.
The mechanism of Sendai virus penetration (fusion of the
viral membrane followed by disassembly) is being studied
by using liposomes in place of the host cell. Fusion of
Sendai virus membranes with liposomes after a 2-h incu-
bation at 370C was previously described (1). Sendai
viruses were also previously shown to be enveloped by
receptor-containing liposopes as in the ingestion step of
endocytosis (2). Investigation of the initial steps of viral
fusion with liposomes composed of phosphatidylcholine
(PC), cholesterol, gangliosides, and phosphatidyletha-
nolamine (PE) showed that the fusion of the viral
membrane with the liposome occurs at the leading edge of
the developing "endocytic vacuole," where there is a
region of membrane with a small radius of curvature (3).
Membrane fusion establishes the continuity of the viral
and liposomal membranes. Viral disassembly with distri-
bution of the viral glycoproteins on the surface of the
liposome and deposition of the viral ribonucleoprotein
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(RNP) inside the liposome follows as a second step. The
present paper shows that liposomes containing only PC,
cholesterol, and gangliosides also fuse with Sendai virus
membranes and that the course of viral disassembly into
these liposomes is variable.
MATERIALS AND METHODS
Egg phosphatidylcholine (PC) was obtained from Avanti Biochemicals
(Birmingham, AL) and cholesterol from Sigma Chemical Co. (St. Louis,
MO). Each gave one spot when 0.8 gmol was chromatographed with
chloroform-methanol-concentrated NH40H (60:25:4, vol/vol/vol) and
with chloroform-methanol-glacial acetic acid-water (65:25:2:4, vol/vol/
vol/vol) on silica gel G thin-layer chromatography (TLC) plates. Bovine
brain gangliosides from Koch-Light Laboratories were purified by chro-
matography with chloroform-methanol-water (60:40:9, vol/vol/vol) +
20 mg KCI/100 ml on silica gel G TLC plates. Chromatography of the
purified gangliosides with chloroform-methanol-2.5 M NH40H (60:35:8,
vol/vol/vol) + 20 mg KCI/100 ml on silica gel G plates confirmed that
they contained five ganglioside species and no contaminating lipids.
Liposomes were made from I ,umol of PC, 0.66 ,mol of cholesterol, and
gangliosides containing 0.1 gmol of N-acetylneuraminic acid. The lipids
were hydrated in 0.15 ml of a buffer containing 137 mM NaCl, 2.7 mM
KCI, 8 mM Na2HPO4, and I mM KH2PO4. Virus was prepared and
electron microscopy was carried out as previously described (3). Virus
(8,192 hemagglutinating units) was adsorbed to the liposomes at 0-40C
for 1 h and then incubated at 370C for 2 h.
RESULTS AND DISCUSSION
Figs. 1-3 show liposomes containing only PC, cholesterol,
and gangliosides which have fused with Sendai virus
membranes. Gangliosides aid fusion because they serve as
Sendai virus receptors (4), and because the resultant
receptor-ligand binding causes envelopment and formation
of regions of liposomes with increased curvature where
fusion occurs (3). Gangliosides may play additional roles
in membrane fusion. Virus binding could cause a local
high concentration of gangliosides, and at high concentra-
tions gangliosides leave the bilayer phase (5). Viral
neuraminidase will release the negatively charged
neuraminic acid from gangliosides which will result in a
decreased negative charge on the external surface of the
bilayer. Some ganglioside species have been shown to
cause red cell fusion (6).
Three patterns of disassembly are seen after a 2-h
incubation of Sendai virus with liposomes containing only
PC, cholesterol, and gangliosides. The first pattern is seen
in Fig. 1 where apparently three viruses have fused and
disassembled into a moderate-sized liposome. The viral
ribonucleoproteins are inside the liposome and the viral
glycoprotein spikes are distributed over the surface of the
liposome. This liposome will have received a considerable
contribution of viral lipids from at least three viruses, so its
final composition will be different from its original compo-
sition. The second pattern is seen in Fig. 2 where a virus
has fused with a liposome but not disassembled. The third
pattern is seen in Fig. 3 where the fused viral and liposo-
mal membranes have not maintained their continuity, so
that part of the viral RNP has been released through the
membrane. Howe and Morgan also noted partial RNP
release after fusion of Sendai virus with erythrocytes (7).
The patterns seen in Figs. 2 and 3 have not been noted
after incubation for 2 h with liposomes that have egg PE in
their composition. This difference may be due to a lipid
requirement for viral disassembly, i.e., egg PE could assist
the packing of the viral proteins into the liposomal
FIGURES 1-3 Liposomes were made and "infected" as described in materials and methods. Arrows indicate positions of viral RNPs
x 53,200.
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membrane. Alternatively, the different patterns could be
due to physical differences in individual virions such as
those that determine the ability of a virion to cause
hemolysis (8).
In summary, Sendai virus can fuse with liposomes
containing only PC, cholesterol, and gangliosides. This
suggests that gangliosides may have a role in membrane
fusion in addition to their receptor function. In liposomes
of this simple composition, the course of disassembly is
variable.
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HUMAN BLOOD PLATELET AGGREGATION-INHIBITORY
TARGET SITES ASSUMED TO INVOLVE MEMBRANE
PHOSPHOLIPIDS
R. P. QUINTANA, A. LASSLO, AND M. DUGDALE,
Departments ofMedicinal Chemistry and Medicine, University of Tennessee Centerfor the Health
Sciences, Memphis, Tennessee 38163 U.S.A.
In an extensive study identifying structural features asso-
ciated with the inhibition of adhesion-release-aggregation
chain reactions in human blood platelets, we employed a
series of carbamoylpiperidine derivatives with systematic
and gradual changes in their molecular constitution,
allowing meaningful interpretation of biological response
variances. Current indications are that the entities concep-
tualized and synthesized in our laboratories (1-6) inhibit
platelet aggregation (culminating at 5 AM concentrations)
by penetrating the lipid bilayer of the platelet membrane
and by interacting, as cations, with negatively charged
phospholipids (e.g., phosphatidylserine and phosphatidyli-
nositol) within the bilayer's inner segment (7). Following
such penetration, those cations could be interfering with
phospholipase-A2 activation by counteracting stimulus-
induced mobilization of Ca"+ ions and Ca"+-dependent
phospholipase-A2 activity (8), thereby rendering platelets
less susceptible to aggregation reactions. Our studies,
employing our mono- and bis(carbamoylpiperidino)al-
kanes and -aralkanes as molecular probes, suggest platelet
aggregation-inhibitory target sites spaced at 8 A, and yield
exacting information on the influence of hydrophobicity,
planarity and geometric isomerism, as well as on the
significance of interatomic distances between, and the
Please address correspondence to Dr. Lasslo.
charge levels of, the amino functions primarily instrumen-
tal in consummating interactions leading to the inhibition
of human blood platelet aggregation.
To confirm these interpretations, the effects of our
carbamoylpiperidine derivatives are being evaluated at
surface pressures estimated to occur in actual platelet
membranes (34 mN m-')(9), on monomolecular films of
phosphatidylserine whose location in the inner segment of
the platelet membrane's lipid bilayer is acknowledged, on
those of phosphatidylcholine, which is known to be a
constituent of the bilayer's outer leaflet, and on related
pure and mixed monolayer systems; e.g., cholesterol/
phospholipid in ratios of 0.5, paralleling those observed in
platelet membranes (10).
MATERIALS AND METHODS
A Payton aggregometer (Payton Associates Inc., Buffalo, NY) with a
dual channel recorder (PFIOHO-D) and a Coulter counter ZBI (Coulter
Electronics Inc., Hialeah, FL) were employed in our platelet aggregation
determinations ( 11); the inhibitory potency of our compounds was
classified: 0 < 10%, 1 + = 1 I-19%, 2+ = 20%-29%, 3+ = 30%-39%,
4+ = 40%-49%, 5 + = 50%-59%, 6 +± 60%. Interfacial and surface
tension values were determined (12) on a Kahlsico duNouy instrument
TE03 (Kahl Scientific Instrument Corp., El Cajon, CA). Surface pres-
sure and potential measurements (13) are being carried out in a recent
version of our previously conceptualized (14) Wilhelmy-type surface
balance system, equipped with a dual pen Omniscribe B-5000 (Houston
Instrument Div., Bausch and Lomb Inc., Austin, TX).
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